Overview
TMDX market data
Price History
TMDX price chart
Valuation & Profitability
- P/E (TTM)
- 15.12 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $4.69 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.92 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $60.11 – $156.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $2.6K · P/B 8.79 · P/S 4.09.
Company News
Atlas Healthcare Fund by VST Capital Entered Eli Lilly at $350 in 2020 — The Stock Now Trades Above $1,200Globenewswire Inc · Jul 17, 2026, 1:15 PM
Evercore ISI Group Maintains Outperform on TransMedics Group, Lowers Price Target to $90Benzinga · Jul 6, 2026, 5:05 PM
Where Will TransMedics Group Stock Be in 10 Years?The Motley Fool · Jul 3, 2026, 4:15 PM
TD Cowen Reiterates Buy on TransMedics Group, Maintains $120 Price TargetBenzinga · Jul 1, 2026, 4:20 PM
What a $722,000 TransMedics Insider Sale Might Mean After a 45% Stock DropThe Motley Fool · Jun 24, 2026, 10:15 PM
Stifel Maintains Hold on TransMedics Group, Raises Price Target to $80Benzinga · Jun 18, 2026, 12:45 PM
Stifel Maintains Hold on TransMedics Group, Lowers Price Target to $75Benzinga · May 26, 2026, 3:58 PM